DOES CALCIUM POTENTIATE THE EFFECT OF ESTROGEN THERAPY ON POSTMENOPAUSAL BONE LOSS

Google Scholar
  • 1 February 1987
    • journal article
    • research article
    • Vol. 2  (1) , 1-9
Abstract
Calcium metabolism was examined in 66 healthy postmenopausal women every 3 months during 2 years of treatment with oral or percutaneous 17.beta.-estradiol combined with different doses of calcium supplementation. Bone mineral content measured in the forearm (single photon absorptiometry) in the spine and in the total skeleton (dual photon absorptiometry) was unchanged in all estrogen-treated groups during the two years of treatment, and the responses in the groups with and without calcium supplementation were not significantly different. Furthermore, the responses were independent of route of administration of the estrogen. Biochemical indices of bone turnover (serum alkaline phosphatase and fasting urinary hydroxyproline/creatinine) decreased highly significantly during estrogen treatment (P < 0.001) independent of route of administration of the estrogen and of the calcium supplementation. We conclude that calcium supplementation has no additive effect to estrogen therapy in the prevention of the early postmenopausal bone loss.